<?xml version="1.0" encoding="UTF-8"?>
<ack id="irv12694-sec-0012">
 <title>ACKNOWLEDGEMENTS</title>
 <p>We thank the staff at the National Institute of Infectious Diseases, Japan; Novartis Vaccines &amp; Diagnostics GmbH &amp; Co.; and the Prefectural Institutes of Public Health at Yamagata and Tochigi for their assistance. We gratefully acknowledge the technical assistance by Roger Wiprächtiger of QIAGEN Hamburg GmbH, Hamburg, Germany. This work was supported, in part, by a grant from the National Institute of Biomedical Innovation to MT, T. Odagiri, NY, HT, and YH [grant number 08‐16]; a grant from the Ministry of Health, Labour and Welfare of Japan to MT, T. Odagiri, NY, H. Takahashi., and YH [grant number h23‐shinkou‐shitei‐021]; and grants from the Japan Agency for Medical Research and Development to NY [grant numbers JP18fk0108212 and JP18fk0108124].</p>
</ack>
